|
Cut Cost of Doing Business
| |
Join the SoCalBio Group Purchasing Program to enjoy significant savings on medical and industrial gas from
For more info, call SoCalBio at
800-418-7079 ext 3
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
| Thanks to SoCalBio Media Partners
|
|
|
|
August 29, 2013
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
enany@socalbio.org
www.socalbio.org
|
|
Past Events
|
Thanks to Participants in the 2013 SoCalBio Workforce Summit Held August 21 at the Van de Kamp Innovation Center
 | |
Cathy Benko of Deloitte expounds the nature of work and education under the corporate lattice paradigm
|
|
 | |
The SoCalBio Workforce Summit honored trainees at LAVC's Biotech Bridge Training Academy
|
|
 | |
Ryan Helwig of Battelle gave an overview of the growth and talent needs of the Los Angeles bioscience industry
|
|
 | |
Willie Zuniga of Grifols presents his company's expansion and job creation plans in East Los Angeles
|
|
 | |
Russ Read of Forsyth Technical Community College explains the mission of c3bc
|
|
 | |
Dr. Anthony Davies of Capricor discusses the future of biomanufacturing jobs
|
|
Click Here to Access Event Photo Album
|
|
Upcoming Events
|
|
Wednesday, September 18, 2013
4:00 PM to 7:00 PM
UCI Calit 2 Auditorium, Irvine, CA
SoCalBio Women, Work & Wisdom (W3) Group Mixer: The Art of Negotiation: Knowing What You Want and How to Get it
| |
Monday, September 23, 2013
10:30 AM to 2:30 PM
SoCalBio's Conference Room
New SoCalBio Member Meeting
| |
Thursday, September 26, 2013
11:00 AM to 3:00 PM
SoCalBio's Conference Room
Howe Will Obama's Healthcare Reforms Impact Your Business?
 |
|
|
Featuring Next Gen. Medtech, Biotech & eHealth Companies
To sponsor or make a business presentation, contact SoCalBio at
|
|
New SoCalBio Members
|
Mesirow Financial (Los Angeles Office)
Mesirow Financial is a diversified financial services firm headquartered in Chicago. Founded in 1937, it is an independent, employee-owned firm with approximately 1,200 employees globally. With expertise in Investment Management, Global Markets, Insurance Services and Consulting, Mesirow Financial strives to meet the financial needs of institutions, public sector entities, corporations and individuals... Learn more
AVI-SPL (Cypress)
AVI-SPL helps customers of all sizes and industries to develop their video communications strategies by providing services that assess, develop and support solutions. ... Learn more
Gordon L. Schooly, Ph.D., LLC (San Diego)
Provides g lobal regulatory and clinical development strategy and execution. FDA, EMA, Health Canada and Australia Health Authority representation. Biostatistics and clinical data management, electronic regulatory submissions including CDISC and C-Path, analytics support to government health agencies and private health care providers .. Learn more
Citrus College (Glendora)
A community college in the San Gabriel Valley ... Learn more
|
|
Sponsored Events
|
October 8 - 9, 2013 in San Francisco, CA
-----------------------------------------------------------------------------------------
November 11 - 13 in Beijing, China
|
|
Reports
| |
Silicon Valley Bank Report Says Big Device M&A Exits Held Their Own in 2012
 Silicon Valley Bank's annual healthcare report notes that the medical device industry generated 17 "Big Exit" acquisitions in 2012, the same as in 2011. Device company IPOs have been all but nonexistent, so the only option for an exit strategy in most cases has become M&A... Read Silicon Valley Bank Report
|
|
FDA Regulations
| |
The FDA's lab rules don't apply to early-stage research
 U.S. federal regulators cleared up some questions for medical device companies about "good laboratory practice," making it clear that the agency's tougher standards don't apply in very early-stage research. The FDA clarified that, when testing a device for basic effectiveness, companies do not need to abide by the more strict quality guidelines that apply to later-stage work ... Read more at Mass Device
|
|
Biosimilars
|
California Assembly Passes a Bill on Biosimilars
 Under the SB 598 by Sen. Jerry Hill, D-San Mateo, pharmacists could substitute a potentially cheaper biosimilar medication if it has been approved by the U.S. Food and Drug Administration. The pharmacy must contact the doctor who issued the prescription within five days to let them know which medication was dispensed... Read more
|
|
Digital Health
|
UCLA Researchers Develop a Smart Phone Test of Kidney Health
 Researchers from UCLA and California NanoSystems Institute are reporting the development of a device that works along with a smartphone to accurately detect albumin in urine. The patient's sample is inserted into the clip-on device along with a control sample and a laser shines a light through the samples while the phone's camera looks at how the result fluoresces. An app on the Android phone then processes the images and provides a reading on the screen ... Read more
|
|
Molecular Diagnostics
|
The Los Angeles-Based Response Genetics Acquires Pathwork Diagnostics
 Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, announced the acquisition of all of the key assets of the Northern California-based Pathwork Diagnostics, including its FDA-cleared, Medicare-reimbursed test for the diagnosis of metastatic, poorly differentiated and undifferentiated cancer ... Read more
|
|
Oncology
| |
Amgen to Acquire the South San Francisco-Based Onyx Pharmaceuticals for $10.4 Billion
 According to the New York Times, "the takeover is the latest within the health care industry, one of the busiest sectors for deal makers as companies seek to gain greater scale. Drug makers have been among the most prolific buyers, seeking new medicines that will refresh aging product lines. Amgen's purchase ranks among the five biggest-ever takeovers of a biotechnology company, according to data from Standard & Poor's Capital IQ. Among the larger transactions were Sanofi-Aventis' $20 billion acquisition of Genzyme and Gilead Sciences' $11 billion purchase of Pharmasset, both announced in 2011"... Read more
|
|
Moving in
|
ImmunoCellular Therapeutics Appoints Anthony J. Gringeri, PhD, as Senior Vice President, Strategic Resources
 Dr. Gringeri brings more than 25 years of executive experience in the pharmaceutical and biotechnology industry to ImmunoCellular, having successfully led multiple functions and cross-functional teams throughout his career, including in the areas of clinical, regulatory and commercial planning and operations, finance, licensing and alliance management. He joins ImmunoCellular from ViaCyte, where he was Vice President and Chief Development Officer, responsible for all preclinical, clinical and regulatory activities ... Read more
|
|
New Funding
| |
Los Angeles-Based Telemedicine Company SnapMD Closes $600,000 Seed Round
 "We could not be more pleased to have Shea Ventures and Whittier Trust as our lead investors. Along with the high-quality individual investors that also participated, the close of this round is one more validation of our business plan and approach to the market," said SnapMD CEO, Dave Skibinski (photo right). "With the successful close of this investment SnapMD is well positioned to take the next steps with our current sales pipeline, continue to add best-of-breed talent, and solidifies our future technology development plans" .. Read Press Release
Neuromodulation Company SetPoint Medical Secures $27 Million in Venture Funding
 Los Angeles startup SetPoint Medical has hauled in $27 million in venture funding to support its neuromodulation device to treat inflammatory diseases, attracting heavyweights like GlaxoSmithKline, Covidien and Boston Scientific. Now, with such high-profile backers lending weight to the technology, the company has reached "an inflection point" in its work to find an alternative to immunosuppressive drugs, CEO Anthony Arnold said ... Learn more about SetPoint Medical
BioBeats, a Los Angeles-Based Mobile Health Company, Raises $650,000 in Seed Funding
 BioBeats -- a startup that seeks merging entertainment and healthcare -- raised money from investors including Will Smith, Damon Wayans, Scooter Braun, Justin Boreta, entertainment lawyer Ken Hertz, AAM CEO Mark Beaven, Cantora Records, ENIAC Ventures, Zhen Fund, and angel investors Gotham Chopra and Kevin Colleran. www.biobeats.com
The Forest Lake-Based ReVision Optics Closes a $55 Million Funding Round
 "We are clearly delighted to complete this strategic financing with such highly regarded healthcare venture investors," said John T. Kilcoyne (photo right), Revision Optics' President and Chief Executive Officer. "Participation by all of our existing investors, Canaan, ProQuest, InterWest and Domain, combined with the capital from new investors JJDC and RMI, provides our company with the necessary financial resources to carry us through the FDA PMA process for the Raindrop Near Vision Inlay and to expand our current commercial footprint outside the U.S.," he added ... Read Press Release
The Los Angeles-Based Meditope Biosciences Announces the Completion of a $3.6 Million Series A Round of Funding
 Meditope -- a spinoff of the City of Hope and alumnus of the 2012 SoCalBio Investor Conference -- has raised $3.6M in a Series A financing led by angel investors to advance its proprietary monoclonal antibody (mAb) linker technology platform. "We are grateful to have had the opportunity to be funded by angel investors, who include pioneers in the biotechnology industry and are supportive of our efforts to quickly advance the development of this exciting new technology platform into the clinic," said Stephanie Hsieh (photo right), the company's President & CEO and a leading member of the SoCalBio W3 Group ... Learn more about Meditope Biosciences
Second Sight Medical Products Files
to Raise $10.5 Million
 The Los Angeles-based medical device company is launching the Argus II. It is the first bionic eye that the FDA approved earlier this year. It was 20 years in the making. The device looks like a sunglass but incorporates a digital camera, which in turn communicates with an implant on the eye. It is aimed at patients suffering from late stage retinitis pigmentosa (RP) ... Read more
San Juan Capistrano-Based Startup Caymus Medical Seeks $10 Million
 Caymus -- a company seeking to develop devices for percutaneous intravascular access and guidewire placement -- has raised $3.9 million so far from 19 investors, according to the filing. Investors' names were not listed and the company didn't specify what it plans to do with the funds .. Read Announcement at MassDevice
|
| Join SoCalBio | |
Become a SoCalBio Member and Save Money by Utlizing the SoCalBio Group Purchasing Program
|
| Jobs Available | |
ChromoLogic (Pasadena)
Second Sight Medical Products (Sylmar)
Alfred Mann Foundation for Scientific
Research (Santa Clarita)
Bioness (Santa Clarita)
Phenomenex (Torrance)
ResearchDx (Irvine)
Avita Medical (Northridge)
Aubrey Group (Irvine)
WaveTec Vision (Aliso Viejo)
Response Genetics (Los Angeles)
Tribogenics (Marina del Rey)
Click to access more info
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
